4th Quarter - Termination
THE CONSILIO GROUP for PARATEK PHARMACEUTICALS
Firm
Client
Income
$24,000
Expenses
—
Terminated
Dec 2, 2024
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, government, and military use
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRANDON KIRBY | — |
| ETHAN MAHLER | — |
| OLIVER MEISSNER | CEO |
Defense DEF
Development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, government, and military use
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRANDON KIRBY | — |
| ETHAN MAHLER | — |
| OLIVER MEISSNER | CEO |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.